Toward an effective use of β-catenin immunohistochemistry in the evaluation of challenging melanocytic lesions

Emily M Erstine¹, Alexander J Lazar^{2

3

4

5}

Affiliations

¹ Departments of Pathology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 85, Houston, TX, 77030, USA. emilyerstine@gmail.com.
² Departments of Pathology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 85, Houston, TX, 77030, USA.
³ Departments of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
⁴ Departments of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
⁵ Departments of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Editorial

Emily M Erstine et al. Virchows Arch. 2019 May.

. 2019 May;474(5):535-537.

doi: 10.1007/s00428-019-02552-6. Epub 2019 Mar 13.

Emily M Erstine¹, Alexander J Lazar^{2

3

4

5}

¹ Departments of Pathology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 85, Houston, TX, 77030, USA. emilyerstine@gmail.com.
² Departments of Pathology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 85, Houston, TX, 77030, USA.
³ Departments of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
⁴ Departments of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
⁵ Departments of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

No abstract available

Comment on

β-Catenin nuclear expression discriminates deep penetrating nevi from other cutaneous melanocytic tumors.
de la Fouchardière A, Caillot C, Jacquemus J, Durieux E, Houlier A, Haddad V, Pissaloux D. de la Fouchardière A, et al. Virchows Arch. 2019 May;474(5):539-550. doi: 10.1007/s00428-019-02533-9. Epub 2019 Feb 12. Virchows Arch. 2019. PMID: 30756182